Presented by: Patrick S. Sullivan, PhD
Presentation title: HIV Epidemiology as a Roadmap to HIV Prevention: Inequities, Contexts, and Responses
The epidemiology of the US HIV epidemic tells the story of where we have been, and charts the path for where we need to go to improve health equity. Through data visualizations, this presentation will highlight the current epidemiology of the US HIV epidemic and link these data to calls for improved surveillance methods and public health actions to address the underlying structural and policy causes for current health inequities in the HIV epidemic.
Patrick Sullivan is the Charles Howard Candler Professor of Epidemiology at Emory University’s Rollins School of Public Health, and Co-Director of the Prevention Sciences Core at Emory’s Center for AIDS Research (CFAR). Before coming to Emory, Patrick worked in at CDC as an EIS officer and serving in HIV Surveillance programs as the Chief of the Behavioral and Clinical Surveillance Branch. He also served in the HIV Vaccine Trial Networks at the Fred Hutchison Cancer research center. Dr. Sullivan’s research focuses on HIV among men who have sex with men, including behavioral research, eHealth and mHealth interventions, and surveillance, and he is a member of the HPTN MSM Scientific Committee. He is Editor in Chief of the Annals of Epidemiology. His research studies currently involve work in the US South and China.
Presented by: Torsten Neilands, PhD
Presentation title: COVID-19 Pandemic-Related Analysis Challenges: The Duo PACT Study
This presentation will focus on adjustments made to the DUO PACT study due to the COVID-19 pandemic and the subsequent interruptions in recruitment, data collection and interviews being conducted remotely. In addition, Dr. Neilands will discuss the strategies for an analytic plan for dealing with missing data, as well as comparing pre-pandemic vs. pandemic differences.
Torsten Neilands is a Professor at the UCSF Center for AIDS Prevention Studies (CAPS) in the Department of Medicine at UCSF and directs the Center’s Methods Core. Originally trained as a social psychologist, Dr. Neilands has participated as statistical co-investigator or consultant on over 60 NIH, CDC, and state projects in the areas of HIV prevention, reproductive health, and tobacco prevention. His methodological areas of interest are multivariate statistical models with a special interest in latent variable models for survey scale development and validation, and mixed effects (i.e., multilevel; HLM) models for clustered and longitudinal data, including dyadic data. His substantive interests include training the next generation of HIV-prevention prevention researchers working in U.S. minority communities.
Presented by: Lucas Wiessing, PhD
Presentation title: Impact of COVID-19 on Services for People Who Inject Drugs in Sites with Recent HIV Outbreaks in Europe, North America and Israel
Areas with recent HIV outbreaks among people who inject drugs (PWID) may be particularly vulnerable to disruptions in HIV/HCV prevention services. The impact of COVID-19 restrictive measures were assessed on these services at 13 sites in Europe, North America and Israel with recent HIV outbreaks in this population. This presentation will cover the results of an online survey and the innovative ways providers responded to continue essential services.
If time allows, Dr. Wiessing will discuss other work at the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) in Lisbon.
Lucas Wiessing is a Principal Scientist in public health at the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) in Lisbon. He co-ordinates international studies on drug use and drug related consequences and interventions across the European Union – including on HIV and viral hepatitis in injecting drug users, harm reduction and drug treatment. He is a national from the Netherlands, holds a PhD in public health (with distinction), speaks six languages and plays flute and saxophone semi-professionally. Lucas collaborates and publishes with many relevant organisations and experts in his field, including in key international expert and advisory groups and scientific conferences. Research Gate Profile.
Presented by: Melody S. Goodman, PhD
Presentation title: The Science of Stakeholder Engagement in Research: Development and Validation of Evaluation Metrics
Stakeholder engagement is a crucial part of participatory public health research, yet the measurement of stakeholder engagement in research is varied, inconsistent, and not methodologically sound. As the level of stakeholder engagement across studies can vary greatly from minimal engagement to fully collaborative partnerships, there is a need for a comprehensively validated quantitative measure of stakeholder engagement in research. We use stakeholder-engaged research approaches and a mixed-methods (qualitative/quantitative) study design to validate a measure to assess the level of stakeholder engagement in research, the research engagement survey tool (REST). Emerging data suggest REST is a valid measure that could potentially assess associations between research outcomes and stakeholder engagement. A 9-item condensed version of REST shows potential to decrease partner burden when measuring stakeholder engagement.
Melody Goodman received her BS summa cum laude in applied mathematics-statistics and economics (double major) from Stony Brook University. She received her MS in biostatistics from the Harvard TH Chan School of Public Health and her PhD from the Department of Biostatistics at Harvard University with minors in theoretical statistics and the social determinants of health disparities. She is the Associate Dean for Research and Associate Professor of Biostatistics, in the School of Global Public Health at New York University.
The National Institutes of Health, Robert Wood Johnson Foundation, Verizon Foundation, Long Island Community Foundation, Patient Centered Outcomes Research Institute, and Susan G. Komen for the Cure have funded her work. She has over 100 peer-reviewed journal articles and two books (2018 Routledge/Taylor & Francis Group); 1) Public Health Research Methods for Partnerships and Practice and 2) Biostatistics for Clinical and Public Health Research. Dr. Goodman is a biostatistician and research methodologist with a large statistical toolbox. Her research interest is on identifying origins of health disparities and developing, as necessary, evidence-based primary prevention strategies to reduce these health disparities.
Presented by: Eli Rosenberg, PhD
Presentation title: The Intersection of the HIV and COVID-19 Epidemics in New York
In this seminar, Dr. Rosenberg will discuss recent studies conducted by the New York State Department of Health and University of Albany School of Public Health to understand the increased risk of COVID-19 diagnosis, hospitalization, and mortality among persons living with HIV.
Eli Rosenberg is an associate professor in the Department of Epidemiology and Biostatistics at the University at Albany School of Public Health. His research centers on applied and analytic epidemiologic studies that address surveillance, prevention, and social determinants of HIV, STI, viral hepatitis, and emerging infectious diseases. Since March 2020, Rosenberg has been providing technical assistance to the State of New York’s COVID-19 response across a range of activities related to understanding SARS-CoV-2 transmission, surveillance, prevention, and treatment.
Presented by: Michelle Nolan, MPH
Presentation title: New York City's Accelerating Overdose Epidemic: Help Put Data Into Action
This talk will describe trends in the overdose epidemic nationally and in New York City. Michelle Nolan will discuss how the New York City Health Department is responding to the overdose epidemic and provide examples of overdose prevention messaging for people to share with their social networks.
Michelle L. Nolan is a Senior Epidemiologist at the New York City Department of Health and Mental Hygiene in the Bureau of Alcohol, Drug Use Prevention, Care and Treatment. In this position, she analyzes real-time data and conducts research to inform and evaluate public health responses aimed at reducing overdose mortality. She holds an MPH in Epidemiology from the Columbia University Mailman School of Public Health and is currently a doctoral student in the Epidemiology Department at Columbia.
Presented by: Dustin T. Duncan, ScD
Presentation title: “…I’m afraid of White people”: Anti-Black Racism, Police Violence and the Health and Wellbeing of Black Cisgender Sexual Minority Men
Anti-Black racism and police violence are predominant social problems in the United States disproportionately impacting cisgender Black boys and men. These social problems have been associated with deleterious health outcomes and health behaviors, including among Black boys and men. Intersectionality theory would suggest that Black sexual minority men would be even more salient and harmful in this vulnerable population. This talk aims to: 1) provide a background on health iniquities, social iniquities and structural racism, 2) provide an overview of police violence and current-related issues, and 3) discuss health research on police violence among Black sexual minority men. The talk will showcase current and future studies Dr. Duncan is involved in, including work with Dr. Maria Khan’s research team (Grant Number: 5R01DA044037) as well as from one of Dr. Duncan’s prospective cohort studies: N2 (Neighborhoods and Networks) Cohort Study, which includes 600 HIV-negative and HIV-positive Black gay, bisexual and other sexual minority men in Chicago IL, Jackson MS, and New Orleans and Baton Rouge LA (Grant Numbers: R01MH112406 and U01PS005122).
Dustin T. Duncan, ScD (he/him) is a social and spatial epidemiologist, studying how neighborhood characteristics influence population health and health disparities. Dr. Duncan’s intersectional research focuses on Black gay, bisexual and other sexual minority men (SMM) and transgender women of color. His research has a strong domestic focus–including in New York City and the Deep South–and his recent work spans the globe such as in West Africa, especially with Columbia’s International Center for AIDS Care and Treatment Programs (ICAP). In addition to HIV epidemiology and sleep epidemiology, his current interests include characterizing the COVID-19 epidemic in the United States and globally, especially among marginalized populations. Notably, his group recently completed the N2 COVID Study, where they surveyed 226 Black SMM and Black transgender women in Chicago on various aspects of COVID-19 from April to July 2020. Methodologically, his research utilizes a geospatial lens to apply advanced geographic information systems, web-based and real-time geospatial technologies, and geospatial modeling techniques. Working in collaborations with scholars across the world, he has over 175 high-impact scientific articles, book chapters, and books and his research has appeared in major media outlets including U.S. News & World Report, The Washington Post, The New York Times and CNN. Dr. Duncan’s work has been funded by the National Institutes of Health, the Centers for Disease Control and Prevention, the HIV Prevention Trials Network, the Robert Wood Johnson Foundation, the Verizon Foundation, and the Aetna Foundation. He currently leads two NIH-funded R01 studies, as well as studies funded by other sources, and mentors K and other awards of junior scientists. He has received several early career and distinguished scientific contribution awards including from the Harvard University T.H. Chan School of Public Health and the Interdisciplinary Association for Population Health Science (IAPHS). In 2020, he received the Mentor of the Year Award from Columbia University Irving Medical Center’s Irving Institute for Clinical and Translational Research.
Presented by: Dustin T. Duncan, ScD
Presentation title: Applications of Geospatial Methods to Study Neighborhoods and Population Health and Health Disparities
The field of neighborhoods and health (sometimes referred to as spatial epidemiology) has grown exponentially in the last twenty years, especially since the publication of the first edition of Neighborhoods and Health edited by Ichiro Kawachi and Lisa Berkman in 2003. This talk aims to: 1) provide an historical overview of neighborhoods and health research, 2) examine recent directions in neighborhoods and health research, and 3) touch on methodological areas including the issue of spatial misclassification. The talk will overview applications of geospatial methods to study neighborhoods in population health and health disparities research with examples from Dr. Duncan’s two prospective cohort studies, which use novel geospatial methods.
Dr. Duncan’s next presentation will be on Thursday, January 28, 2021 from 10-11:30 am. The topic will be determined by polling of our audience on January 21st.
Dustin T. Duncan, ScD (he/him) is a social and spatial epidemiologist, studying how neighborhood characteristics influence population health and health disparities. Dr. Duncan’s intersectional research focuses on Black gay, bisexual and other sexual minority men (SMM) and transgender women of color. His research has a strong domestic focus–including in New York City and the Deep South–and his recent work spans the globe such as in West Africa, especially with Columbia’s International Center for AIDS Care and Treatment Programs (ICAP). In addition to HIV epidemiology and sleep epidemiology, his current interests include characterizing the COVID-19 epidemic in the United States and globally, especially among marginalized populations. Notably, his group recently completed the N2 COVID Study, where they surveyed 226 Black SMM and Black transgender women in Chicago on various aspects of COVID-19 from April to July 2020. Methodologically, his research utilizes a geospatial lens to apply advanced geographic information systems, web-based and real-time geospatial technologies, and geospatial modeling techniques. Working in collaborations with scholars across the world, he has over 150 high-impact scientific articles, book chapters, and books and his research has appeared in major media outlets including U.S. News & World Report, The Washington Post, The New York Times and CNN. Dr. Duncan’s work has been funded by the National Institutes of Health, the Centers for Disease Control and Prevention, the HIV Prevention Trials Network, the Robert Wood Johnson Foundation, the Verizon Foundation, and the Aetna Foundation. He currently leads two NIH-funded R01 studies, as well as studies funded by other sources, and mentors K and other awards of junior scientists. He has received several early career and distinguished scientific contribution awards including from the Harvard University T.H. Chan School of Public Health and the Interdisciplinary Association for Population Health Science (IAPHS). In 2020, he received the Mentor of the Year Award from Columbia University Irving Medical Center’s Irving Institute for Clinical and Translational Research.
Presented by: Don Des Jarlais, PhD
Presentation title: Ending an HIV Epidemic Among PWID in a Middle Income Country
Viet Nam experienced a large HIV epidemic among PWID in the 1990s, with seroprevalence reaching over 50% in some provinces. Since the 2000s, Viet Nam gradually implemented “combined prevention and care for HIV among PWID.” Dr. Des Jarlais will present on four large RDS studies of PWID the DRIVE Study team conducted in the city of Hai Phong, Viet Nam. (N’s of approximately 1500 per annual survey, with cohort studies of approximately 800/year.) HIV incidence was was < 1/1000 person-years and the 90-90-90 treatment goals were achieved for the PWID population. The involvement of drug user community-based organizations was critical to the success.
For over 30 years Don Des Jarlais has been conducting HIV/AIDS research among persons who inject drugs (PWID). He is PI of the “Risk Factors” study (R01DA003574), which was instrumental in tracking the HIV/AIDS epidemic in New York City. This study has been funded by the National Institute on Drug Abuse since 1983 and is the longest continuously funded study on HIV/AIDS in persons who use drugs. He has conducted HIV/AIDS research nationally (Seattle, CDC CIDUS studies, national syringe exchange survey) and internationally (in over 20 different countries). He has served as a consultant on these issues to the World Health Organization, the National Institutes of Health and the U.S. Centers for Disease Control and Prevention.
Presented by: Vincent Guilamo-Ramos, PhD, MPH, LCSW, PMHNP, ANP-BC, AAHIVS
Presentation title: Community Engaged Interventions to Address Overlapping Epidemics Among Latinos in the United States
Latinos in the US are impacted by overlapping and intersecting epidemics. National public health efforts to address HIV, HCV, drug use, and more recent infectious disease outbreaks such as COVID-19 have inadequately recognized Latinos as an important disparity population. This omission has inadvertently resulted in the prevention needs of Latino communities remaining largely invisible. The presentation seeks to: 1) characterize HIV, HCV, drug use, and COVID-19 disparities among Latinos in the US; 2) highlight the role of meaningful community engagement for achieving reductions in Latino health disparities; 3) discuss the implications of researchers’ social position relative to community members (i.e., positionality) for research that successfully advances the uptake, adherence, infrastructure, and sustainability of evidence-based programs within Latino communities; and 4) consider these concepts in relation to traditional notions of “scientific rigor.”
Vincent Guilamo-Ramos is a professor and Associate Vice Provost of Mentoring and Outreach Programs at New York University (NYU). He is the director and founder of the Center for Latino Adolescent and Family Health (CLAFH). Dr. Guilamo-Ramos also serves as the Pilot Projects and Mentoring Core Director at CDUHR at the NYU School of Global Public Health. Dr. Guilamo-Ramos is a clinical social worker and nurse practitioner, and is board certified in HIV/AIDS nursing (ACRN) and as a HIV specialist (AAHIVS). Clinically, he has expertise in the primary care of HIV positive adolescents, provision of pre-exposure prophylaxis for high-risk youths, and screening and treatment of sexually transmitted diseases. Dr. Guilamo-Ramos studies the role of families in promoting adolescent health, with a special focus on preventing HIV/AIDS, sexually transmitted infections, unplanned pregnancies, and improving treatment outcomes for HIV positive and at-risk youth. He is a Fellow of the American Academy of Social Work and Social Welfare. He serves as Vice Chair of the Board of Directors for the Latino Commission on AIDS, and is a board member of the Power to Decide. Dr. Guilamo-Ramos received his PhD from SUNY Albany, and his MSW and MPH degrees from NYU. In addition, he holds an MS from the Robert F. Wagner Graduate School of Public Service at NYU and an MSN from the Duke University School of Nursing.
Presented by: Linda M. Collins, PhD
Presentation title: A Brief Introduction to Intervention Optimization
In this presentation Dr. Collins will briefly describe the multiphase optimization strategy (MOST). This is a framework that can be used to optimize behavioral, biobehavioral, biomedical, and social-structural interventions by removing wasteful inactive components and balancing effectiveness against affordability and implementability.
Linda M. Collins is co-director of the CDUHR Methods Core and Professor of Social and Behavioral Sciences and Professor of Biostatistics in the School of Global Public Health, New York University. Her primary research interest is advancement and dissemination of the multiphase optimization strategy (MOST), and applications of MOST to develop interventions that are not only effective, but also efficient, economical, and scalable.